Novel therapies, such as GLP-one receptor agonists and SGLT2 inhibitors, are safer due to the fact they do not trigger hypoglycemia, are weight neutral or result in weight loss and blood pressure and impact vascular complications favorably. PCOS is An important risk factor for type 2 diabetes as it is https://health-supplements55318.ltfblog.com/26394993/indicators-on-diabetes-patch-you-should-know